SARSâCoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice.
SARS-CoV-2 RBD219-N1C1:一种酵母表达的 SARS-CoV-2 重组受体结合域候选疫苗可刺激小鼠产生病毒中和抗体和 T 细胞免疫
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2021.1901545
Pollet Jeroen, Chen Wen-Hsiang, Versteeg Leroy, Keegan Brian, Zhan Bin, Wei Junfei, Liu Zhuyun, Lee Jungsoon, Kundu Rahki, Adhikari Rakesh, Poveda Cristina, Villar Maria Jose, de Araujo Leao Ana Carolina, Altieri Rivera Joanne, Momin Zoha, Gillespie Portia M, Kimata Jason T, Strych Ulrich, Hotez Peter J, Bottazzi Maria Elena